STOCK TITAN

Electrocore SEC Filings

ECOR NASDAQ

Welcome to our dedicated page for Electrocore SEC filings (Ticker: ECOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Untangling electroCore’s SEC paperwork can feel like neuromodulation without anesthesia—hundreds of pages of FDA jargon, patent claims, and cash-burn math buried in footnotes. If you have ever searched for “electroCore SEC filings explained simply” or wondered why a single 8-K could move the stock after a new migraine clearance, you are not alone.

Stock Titan turns that headache into clarity. Our AI-powered summaries translate every electroCore annual report 10-K simplified, each quarterly earnings report 10-Q filing, and all electroCore 8-K material events explained into plain English. Need real-time alerts on electroCore Form 4 insider transactions? We stream them the moment they hit EDGAR—so monitoring electroCore insider trading Form 4 transactions or tracking electroCore executive stock transactions Form 4 becomes effortless. Interactive dashboards pair key metrics—nVNS revenue, R&D outlays, and liquidity runway—with expert context, letting you focus on decisions, not document mining.

Dive deeper when questions arise: How did gammaCore sales trend this quarter? Our electroCore earnings report filing analysis highlights device unit growth. Curious about board pay? The electroCore proxy statement executive compensation section is pre-tagged and summarized. Want a quick refresher before earnings? Understanding electroCore SEC documents with AI surfaces the exact risk-factor changes since last year. From electroCore quarterly earnings report 10-Q filing insights to electroCore Form 4 insider transactions real-time, every disclosure is at your fingertips—updated continuously, explained clearly, and ready to guide your next move.

Rhea-AI Summary

electroCore, Inc. director Patricia Wilber received an annual award of 19,011 restricted stock units (RSUs) on 09/02/2025 that vest in 12 equal monthly installments from the grant date, but will vest in full earlier if the company holds its next annual meeting or upon a change of control, provided she remains in continuous service.

Following this grant, Ms. Wilber beneficially owns 72,325 shares, which includes 16,583 shares that vested from prior RSU grants and were previously reported. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Julie Ann Goldstein, a director of electroCore, Inc. (ECOR), reported an award of 19,011 Annual Deferred Stock Units on 09/02/2025. The units were issued at a $0.00 price and vest in 12 equal monthly installments from the grant date; they vest in full earlier if the reporting person remains in service until the close of business one business day prior to the issuer's next annual stockholder meeting or immediately prior to a change of control. Following the grant, the filing reports 101,387 shares beneficially owned, which includes 10,000 previously vested shares and 1,665 shares held in NeuroSpine Ventures for which the reporting person disclaims beneficial ownership except for pecuniary interest. The Form 4 was signed by attorney-in-fact John L. Cleary, II on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

electroCore, Inc. director Thomas J. Errico reported an award of 26,615 annual deferred stock units (DSUs) granted on 09/02/2025. The DSUs vest in 12 equal monthly installments from the grant date but will vest in full earlier if the holder remains in service until the next annual meeting or upon a change of control. Following the award, Errico beneficially owns 308,016 shares, composed of 217,051 directly owned shares, 1,296 shares held in a family trust, 11,000 held in another trust, and 52,054 shares that vested from prior DSUs. The DSUs carry no purchase price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

electroCore, Inc. director John P. Gandolfo was granted 19,011 Annual Deferred Stock Units on 09/02/2025 that vest in 12 equal monthly installments from the grant date, but accelerate to full vesting either one business day prior to the issuer's next annual stockholder meeting or immediately prior to a change of control, provided the reporting person remains in continuous service. After the grant, Mr. Gandolfo beneficially owns 88,098 shares, which includes 65,021 shares that had previously vested from earlier deferred unit grants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.76%
Tags
current report
-
Rhea-AI Summary

Thomas J. Errico, a director of electroCore, Inc. (ECOR), purchased 15,000 common shares on 08/11/2025 at a weighted-average price of $4.47 per share. After the purchase he beneficially owns 281,401 shares, consisting of 217,051 shares owned directly, 1,296 and 11,000 shares held in two trusts, 50,672 vested Deferred Stock Units (DSUs), and 1,382 DSUs that vest monthly through September 3, 2025 (with full vesting earlier upon specified events). The filer notes a price range of $4.34 to $4.55 and will provide a breakdown of purchases on request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Daniel S. Goldberger, Chief Executive Officer and director of electroCore, purchased 1,000 shares of common stock on 08/11/2025 at a weighted-average price of $4.23 per share (purchase prices ranged from $4.225 to $4.25). After the purchase he beneficially owns 291,565 shares. The filing notes that this total includes previously issued restricted stock units of 75,000 (25,000 vested; 50,000 vesting one-half on January 16, 2026 and January 16, 2027), 50,000 (33,333 vested; 16,667 vesting August 4, 2026), and 40,000 (vesting in one-third increments on January 18, 2026, January 18, 2027, and January 18, 2028).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.94%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
quarterly report
-
Rhea-AI Summary

electroCore, Inc. (ECOR) – Form 4 filing: On 08/01/2025 director James C. Theofilos was granted 22,156 restricted stock units (RSUs) under the company’s 2018 Omnibus Equity Compensation Plan. Each RSU converts into one common share and vests in 12 equal quarterly installments over 36 months. The award was recorded at $0 purchase price, indicating an incentive grant rather than an open-market buy. After the transaction, Theofilos’ direct beneficial ownership increased to 23,547 shares, consisting of 22,156 unvested RSUs and 1,391 previously held common shares. No shares were sold, no derivative securities were reported, and the form was signed on 08/05/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.38%
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.38%
Tags
insider

FAQ

What is the current stock price of Electrocore (ECOR)?

The current stock price of Electrocore (ECOR) is $4.925 as of September 4, 2025.

What is the market cap of Electrocore (ECOR)?

The market cap of Electrocore (ECOR) is approximately 38.8M.
Electrocore

NASDAQ:ECOR

ECOR Rankings

ECOR Stock Data

38.79M
5.29M
30.23%
15.51%
5.45%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY